<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rauner M</submitter><funding>Versus Arthritis</funding><pagination>731217</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8686830</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>The availability of large human datasets for genome-wide association studies (GWAS) and the advancement of sequencing technologies have boosted the identification of genetic variants in complex and rare diseases in the skeletal field. Yet, interpreting results from human association studies remains a challenge. To bridge the gap between genetic association and causality, a systematic functional investigation is necessary. Multiple unknowns exist for putative causal genes, including cellular localization of the molecular function. Intermediate traits ("endophenotypes"), e.g. molecular quantitative trait loci (molQTLs), are needed to identify mechanisms of underlying associations. Furthermore, index variants often reside in non-coding regions of the genome, therefore challenging for interpre</pubmed_abstract><journal>Frontiers in endocrinology</journal><pubmed_title>Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques.</pubmed_title><pmcid>PMC8686830</pmcid><funding_grant_id>22044</funding_grant_id><pubmed_authors>Rauner M</pubmed_authors><pubmed_authors>Karasik D</pubmed_authors><pubmed_authors>Prijatelj V</pubmed_authors><pubmed_authors>Giralt NG</pubmed_authors><pubmed_authors>van Hul W</pubmed_authors><pubmed_authors>Foessl I</pubmed_authors><pubmed_authors>Banerjee B</pubmed_authors><pubmed_authors>Soe K</pubmed_authors><pubmed_authors>Reppe S</pubmed_authors><pubmed_authors>Balcells S</pubmed_authors><pubmed_authors>Busse B</pubmed_authors><pubmed_authors>van de Peppel J</pubmed_authors><pubmed_authors>Pavlos NJ</pubmed_authors><pubmed_authors>Lopez NA</pubmed_authors><pubmed_authors>Bergen D</pubmed_authors><pubmed_authors>Calado A</pubmed_authors><pubmed_authors>Gabet Y</pubmed_authors><pubmed_authors>van der Eerden B</pubmed_authors><pubmed_authors>Soldatovic I</pubmed_authors><pubmed_authors>Grinberg D</pubmed_authors><pubmed_authors>Rivadeneira F</pubmed_authors><pubmed_authors>Lovsin NM</pubmed_authors><pubmed_authors>Solan XN</pubmed_authors><pubmed_authors>Kague E</pubmed_authors><pubmed_authors>Formosa MM</pubmed_authors><pubmed_authors>Ostanek B</pubmed_authors><pubmed_authors>Marc J</pubmed_authors><pubmed_authors>Douni E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Perspective of the GEMSTONE Consortium on Current and Future Approaches to Functional Validation for Skeletal Genetic Disease Using Cellular, Molecular and Animal-Modeling Techniques.</name><description>The availability of large human datasets for genome-wide association studies (GWAS) and the advancement of sequencing technologies have boosted the identification of genetic variants in complex and rare diseases in the skeletal field. Yet, interpreting results from human association studies remains a challenge. To bridge the gap between genetic association and causality, a systematic functional investigation is necessary. Multiple unknowns exist for putative causal genes, including cellular localization of the molecular function. Intermediate traits ("endophenotypes"), e.g. molecular quantitative trait loci (molQTLs), are needed to identify mechanisms of underlying associations. Furthermore, index variants often reside in non-coding regions of the genome, therefore challenging for interpre</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-04T08:52:35.306Z</modification><creation>2022-02-11T14:35:47.471Z</creation></dates><accession>S-EPMC8686830</accession><cross_references><pubmed>34938269</pubmed><doi>10.3389/fendo.2021.731217</doi></cross_references></HashMap>